 |
 |

Prevention of Atrial Fibrillation Following Cardiac Surgery
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their randomized controlled trial of prophylactic amiodarone therapy for the prevention of atrial fibrillation after heart surgery, Dr Mitchell and colleagues1 found that treatment with amiodarone compared with placebo resulted in a 48% reduction in the primary end point, defined as an atrial tachyarrhythmia lasting 5 minutes or longer that prompted treatment by the attending physician. We have a number of questions related to the study design and analysis.
First, the potential confounding effect of -blocker withdrawal was not considered.2 Patients who have had treatment with a -blocker withdrawn have been found to have twice the likelihood of developing postoperative atrial fibrillation.3 In the present study, rates of -blocker use both before and after surgery were recorded, so withdrawal rates of -blockers could be derived and reported.
Second, the authors state that serum amiodarone levels were determined on the day of surgery but do not specifically . . . [Full Text of this Article]
Brian J. Potter, MD
brian.potter@umontreal.ca Notre-Dame Hospital
Jacques LeLorier, MD, PhD, FRCPC
Centre de Recherche de l'Hôtel-Dieu du CHUM Centre Hospitalier de lUniversité de Montréal Montréal, Quebec
RELATED ARTICLES
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A Randomized Controlled Trial
, , , , , , , , , , , and
JAMA. ;294():3093-3100.
FULL TEXT
Prevention of atrial fibrillation following cardiac surgery.
JAMA. ;295():2247-2247.
FULL TEXT
Prevention of atrial fibrillation following cardiac surgery.
JAMA. ;295():2247-2248.
FULL TEXT
Prevention of Atrial Fibrillation Following Cardiac Surgery--Reply
and
JAMA. ;295():2248-2248.
FULL TEXT
|